[EN] HEXAHYDROPYRROLOTHIAZINE COMPOUNDS<br/>[FR] COMPOSÉS D'HEXAHYDROPYRROLOTHIAZINE
申请人:EISAI R&D MAN CO LTD
公开号:WO2014013076A1
公开(公告)日:2014-01-23
A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 to R9 are as defined in the specification and which compound has an Αβ production inhibitory effect and may be useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Αβ and typified by Alzheimer-type dementia (AD) or Down's syndrome.
公式(I)的化合物或其药用盐,其中R1至R9如规范中定义,并且该化合物具有抑制Αβ产生的效果,可能作为一种预防或治疗剂用于由Αβ引起的以阿尔茨海默症(AD)或唐氏综合征为特征的神经退行性疾病。